Diabetes mellitus and tuberculosis: programmatic management issues

• Published in: The international journal of tuberculosis and lung disease Vol. 19; no. 8; pp. 879 - 886
• Main Authors: Harries, A. D., Kumar, A. M. V., Satyanarayana, S., Lin, Y., Zachariah, R., Lönnroth, K., Kapur, A.
• Format: Journal Article
• Language: English
• Published: France International Union Against Tuberculosis and Lung Disease 01.08.2015
• Subjects: Bi-Directional Screening; Cooperative Behavior; Diabetes Mellitus - diagnosis; Diabetes Mellitus - epidemiology; Dm-Tb Interaction; Global Health; Health Policy; Humans; Mass Screening - methods; Medicin och hälsovetenskap; Policy Making; Programmatic Challenges; Tuberculosis - diagnosis; Tuberculosis - epidemiology; World Health Organization
• ISSN: 1027-3719; 1815-7920; 1815-7920
• DOI: 10.5588/ijtld.15.0069

In August 2011, the World Health Organization and the International Union Against Tuberculosis and Lung Disease launched the Collaborative Framework for Care and Control of Tuberculosis (TB) and diabetes mellitus (DM) to guide policy makers and implementers in combatting the epidemics of both diseases. Progress has been made, and includes identifying how best to undertake bidirectional screening for both diseases, how to provide optimal treatment and care for patients with dual disease and the most suitable framework for monitoring and evaluation. Key programmatic challenges include the following: whether screening should be directed at all patients or targeted at those with high-risk characteristics; the most suitable technologies for diagnosing TB and diabetes in routine settings; the best time to screen TB patients for DM; how to provide an integrated, coordinated approach to case management; and finally, how to persuade non-communicable disease programmes to adopt a cohort analysis approach, preferably using electronic medical records, for monitoring and evaluation. The link between DM and TB and the implementation of the collaborative framework for care and control have the potential to stimulate and strengthen the scale-up of non-communicable disease care and prevention programmes, which may help in reducing not only the global burden of DM but also the global burden of TB.